Chimerix Inc. (CMRX)

2.44
NASDAQ : Health Technology
Prev Close 2.34
Day Low/High 2.33 / 2.47
52 Wk Low/High 1.74 / 4.40
Avg Volume 370.90K
Exchange NASDAQ
Shares Outstanding 61.27M
Market Cap 143.37M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
Chimerix (CMRX) Stock Rises in Pre-Market Trading on Point72 Stake

Chimerix (CMRX) Stock Rises in Pre-Market Trading on Point72 Stake

Chimerix (CMRX) stock is increasing in pre-market trading on Thursday after Point72 Asset Management disclosed a 5.3% stake in the biotechnology company.

Stock Futures Slip as Jobless Claims Climb

Stock Futures Slip as Jobless Claims Climb

Stock futures slide on the final trading day of the year after weekly jobless claims rise faster than expected.

Trade-Ideas: Chimerix (CMRX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Chimerix (CMRX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Chimerix (CMRX) as a strong on high relative volume candidate

Analysts' Actions -- Rockwell Collins, Joy Global, Tupperware, Glu Mobile and More

Analysts' Actions -- Rockwell Collins, Joy Global, Tupperware, Glu Mobile and More

Here are Wednesday's top research calls, including a downgrade for Glu Mobile, an earnings estimates boost for Rockwell Collins, and an earnings estimates cut for Joy Global and Tupperware.

4 Stocks Under $10 to Trade for Big Breakouts

4 Stocks Under $10 to Trade for Big Breakouts

These stocks trading for less than $10 a share are within range of triggering breakout trades.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DGICA Downgrades: AEY, ATAI, CMRX, EOG, EQIX, GLNG, GLUU, KSU Initiations: UBS Read on to get TheStreet Quant Ratings' detailed report:

Chimerix (CMRX) Rebounds Despite JPMorgan Downgrade

Chimerix (CMRX) Rebounds Despite JPMorgan Downgrade

Chimerix (CMRX) is rallying in morning trading after yesterday's sharp decline, even though JPMorgan downgraded the stock to 'neutral' from 'overweight' on Monday afternoon.

Today's Pre-Market Mover With Heavy Volume: Chimerix (CMRX)

Today's Pre-Market Mover With Heavy Volume: Chimerix (CMRX)

Trade-Ideas LLC identified Chimerix (CMRX) as a pre-market mover with heavy volume candidate

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By Chimerix, Inc. And Certain Officers And Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By Chimerix, Inc. And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Chimerix, Inc.

Why Chimerix (CMRX) Stock Is Tanking Today

Why Chimerix (CMRX) Stock Is Tanking Today

Chimerix (CMRX) stock is plunging in morning trading on Monday after a Phase 3 trial of the company's antiviral Brincidofovir failed to meet expectations.

Chimerix (CMRX): Today's Weak On High Volume Stock

Chimerix (CMRX): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Chimerix (CMRX) as a weak on high relative volume candidate

Short Interest Decreases By 15.5% For CMRX

Short Interest Decreases By 15.5% For CMRX

The most recent short interest data has been released by the NASDAQ for the 09/30/2015 settlement date, which shows a 568,131 share decrease in total short interest for Chimerix Inc. , to 3,102,508, a decrease of 15.48% since 09/15/2015.

Strong On High Volume: Chimerix (CMRX)

Strong On High Volume: Chimerix (CMRX)

Trade-Ideas LLC identified Chimerix (CMRX) as a strong on high relative volume candidate

Chimerix Presents New Research On Hospital Readmission Rates In Hematopoietic Cell Transplant Recipients

Chimerix Presents New Research On Hospital Readmission Rates In Hematopoietic Cell Transplant Recipients

Opportunistic Infections Caused by dsDNA Viruses Occur Early in the Post-Transplant Period and Support Need for Preventive Therapies

Trade-Ideas: Chimerix (CMRX) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Chimerix (CMRX) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Chimerix (CMRX) as a "perilous reversal" (up big yesterday but down big today) candidate

Battleground: Will This $5 Biotech Stock Go To $22 Or $1.50?

Battleground: Will This $5 Biotech Stock Go To $22 Or $1.50?

In the last two days, analysts have issued widely divergent opinions and price targets on Keryx Biopharmaceuticals, a small-cap biotech company focused on the treatment of renal diseases.

CMRX: Insiders vs. Shorts

CMRX: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 07/31/2015 settlement date, and Chimerix Inc. is one of the most shorted stocks of the Russell 3000, based on 7.13 "days to cover" versus the median component at 5.46.

New Lifetime High Reached By Chimerix (CMRX)

New Lifetime High Reached By Chimerix (CMRX)

Trade-Ideas LLC identified Chimerix (CMRX) as a new lifetime high candidate

TheStreet Quant Rating: D (Sell)